← All trials
NCT00128583
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 31, 2005
- Primary completion
- —
- Completion date
- —
- First posted
- Aug 10, 2005
- Last posted
- Dec 19, 2013
- Enrollment
- —
- Arms / groups
- — / —
- Source
- AACT · ctgov ingestion
Sponsors
- CancerVax CorporationLead sponsor
- CancerVax CorporationStudy chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.